1. Centers for Disease Control and Prevention. Revised Surveillance Case Definition for HIV Infection. MMWR. 2014 63(RR03);1-10.
2. Jones JL, Hanson DL, Dworkin MS, et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ 1999; 48:1-22.
3. Wood BR. The natural clinical features of HIV infection in adults and adolescents. Erişim: https://www.uptodate.com/contents/the-natural-history-and-clinical-features-of-hiv-infecti-
on-in-adults-and-adolescents (Erişim tarihi: 14 Mayıs 2024).
4. Crowell TA, Colby DJ, Pinyakorn S, et al. Acute Retroviral Syndrome Is Associated With High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments.
Clin Infect Dis 2018; 66:1540-1549.
5. Braun DL, Kouyos RD, Balmer B, et al. Frequency and Spectrum of Unexpected Clinical Manifestations of Primary HIV-1 Infection. Clin Infect Dis 2015; 61:1013-1021.
6. Kerin T, Cortado R, Paiola SG et al. Demographics of Youth With Newly Diagnosed Acute/Recent HIV Infection in Adolescent Trials Network 147: Early Treatment of Acute HIV Infection.
J Adolesc Health 2024; 74:573-581.
7. Eshleman, SH. The Levi Syndrome: Characteristics Of Early HIV Infection With Cabotegravir For Prep. Conference on Retroviruses and Opportunistic Infections, 2023. Erişim: https://www.
croiconference.org/abstract/the-levi-syndrome-characteristics-of-early-hiv-infection-with-cabotegravir-for-prep. (Erişim tarihi:14 Mayıs 2024)
8. Gupta KK. Acute immunosuppression with HIV seroconversion. N Engl J Med 1993; 328:288-289.
9. Vento S, Di Perri G, Garofano T, et al. Pneumocystis carinii pneumonia during primary HIV-1 infection. Lancet 1993; 342:24-25.
10. Moss PJ, Read RC, Kudesia G, McKendrick MW. Prolonged cryptosporidiosis during primary HIV infection. J Infect 1995;30:51-53.
11. Pedersen C, Lindhardt BO, Jensen BL, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ 1989; 299:154-157.
12. Niu MT, Stein DS, Schnittman SM. Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infe-
ctions. J Infect Dis 1993; 168:1490-1501.
13. Lavreys L, Baeten JM, Chohan V, et al. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women.
Clin Infect Dis 2006; 42:1333-1339.
14. Bogoch II, J R Andrews JR, Nagami EH,et al. Clinical predictors for the aetiology of peripheral lymphadenopathy in HIV-infected adults. HIV Med 2013:14:182-186.
15. Osmond D, Chaisson R, Moss A, et al. Lymphadenopathy in asymptomatic patients seropositive for HIV. N Engl J Med 1987; 317:246. doi: 10.1056/NEJM198707233170413.
16. Mitja O, Alemany A, Marks M, et al. Mpox in people with advanced HIV infection: a global case series. Lancet 2023; 401: 939-949.
17. Rodes B, Cadinanos J, Esteban-Cantos, Centeno JR, , Arribas JR. Ageing with HIV: Challenges and biomarkers. Lancet, eBioMedicine 2022;77: 103896.
18. Opie J. Haematological complications of HIV infection. S Afr Med J 2012;102(6):465-468